CXCL9 has been confirmed to be associated with ovarian cancer prognosis; it is related to the survival rate of patients with high-grade serous ovarian cancer (HGSC) and is an independent marker of good prognosis in HGSC patients [52]. This evidence concerns the gene CXCL9 and ovarian carcinoma.